The rising frequency of cardiovascular and respiratory illnesses, as well as industrial partnerships by major market players, are projected to propel the extracorporeal membrane oxygenation system market forward.
The primary challenges impeding the growth of the worldwide extracorporeal membrane oxygenation system market are ECMO system issues such as internal bleeding, blood clotting, or technical failure, as well as the high cost of ECMO equipment.
ALung Devices, Inc., the leading developer of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure, was bought by LivaNova PLC, a worldwide medical technology business, in May 2022.
According to Coherent Market Insights, Global Extracorporeal Membrane Oxygenation System Market is estimated to be valued at US$ 316.5 million in 2022 and is expected to exhibit a CAGR of 5.3% during the forecast period (2022-2030).
Leading Companies in the Extracorporeal Membrane Oxygenation System Industry:
1. Medtronic
The company was founded in 1949 and is headquartered in Dublin, Ireland. Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. On August 30, 2022 Medtronic plc announced that it has completed the acquisition of Affera, Inc. This acquisition expands the company's cardiac ablation portfolio to include its first-ever cardiac mapping and navigation platform that encompasses a differentiated, fully integrated diagnostic, focal pulsed field and radiofrequency ablation solution.
2. Getinge AB
The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden. It offers products thorugh distributors in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. On April 27, 2022, Getinge announced an agreement to acquire FLUOPTICS SAS, a French based leader in fluorescence imaging as an aid to surgery.
3. LivaNova PLC
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. LivaNova PLC was founded in 1987 and is headquartered in London, the United Kingdom. On December 2022, LivaNova PLC Acquires ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure.
4. Terumo Corporation
Terumo Corporation was incorporated in 1921 and is headquartered in Tokyo, Japan. TMC provides products and services across four divisions: Terumo Business Edge, which provides healthcare systems with solutions designed to reduce care variation, improve quality metrics, minimize cost and maximize revenue; Terumo Interventional Systems (TIS), which offers solutions for entry site management and lesion access; Terumo Medical Products (TMP), which provides devices for injection and infusion therapy; and Terumo Pharmaceutical Solutions (TPS), which develops drug delivery devices
5. XENIOS AG
XENIOS is the therapy and technology leader in minimally invasive lung and heart assist. Xenios, a Fresenius Medical Care company, we offer ECMO treatments for patients suffering from cardiac and/or pulmonary failure. Founded in2013. Headquartered in Heilbronn Germany. Xenios was Acquired by Fresenius Medical Care & Co. KGaA, Germany’s largest medical device company on November 2016.
6. OriGen Biomedical
Origen Biomedical, Inc. manufactures medical devices. The Company offers cryopreservation, cell culture products, tissuevault cryogenic freezing bags, dmso and dextran solutions, spike adapters, syringes, sterile components, and manifold sets. Origen Biomedical serves clients in the United States and Europe. The company is headquartered in United States and founded in 1996. The company has manufacturing facilities certified by the FDA and ISO.
7. EUROSETS NIPRO
Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses. It serves customers in Japan, the Americas, Europe, and rest of Asia. The company was founded in 1947 and is headquartered in Osaka, Japan.
8. MicroPort Scientific Corporation
MicroPort Scientific Corporation, an investment holding company, manufactures, and markets, and distributes medical devices in the People's Republic of China, North America, Europe, other Asian countries, South America, and internationally. MicroPort Scientific Corporation was founded in 1998 and is headquartered in Shanghai, the People's Republic of China. On October 2021, ECLS Company Hemovent has been Acquired by MicroPort and Received Investments in Expansion of German Operations.
*Definition- Extracorporeal membrane oxygenation (ECMO) is a life-sustaining technology that provides cardiac and respiratory support to individuals with severe respiratory failure.
